since 04/2020 |
Early Stage Researcher in the ETN Magicbullet::Reloaded at Heidelberg Pharma Research GmbH/ Germany PhD topic: Improving pharmacokinetics properties of small molecule Amatoxin conjugates for targeted cancer therapy. Heidelberg Pharma Research GmbH, Dr. Andreas Pahl, Prof. Dr. Norbert Sewald, Dr. Torsten Hechler |
10/2012 – 10/2018 |
M.Sc. in Pharmacy and Industrial Pharmacy at the University of Siena/Italy. Master thesis: Role of Sestrin 1 and 2 in the regulation of DNA damage response in Human A549 lung cancer cell. Trinity Biomedical Science Institute-Trinity College Dublin/Ireland, Prof. Dr. Maria Frosini, Prof. Dr. Andrei Budanov |
10/2019 – 03/2020 |
Research Training at Heidelberg Pharma Research GmbH/Germany. Production, manipulation and quality analysis of ATACs: ADCs based on the conjugation with Amatoxins. |
02/2019 – 07/2019 |
Erasmus for traineeship program. Internship at Molecular-Oncology laboratory of the General Hospital of Valencia/Spain. Testing L-glutamine anti-EGFR conjugates in Human lung cancer cells. Dr.Silvia Calabuig Dr.Eloisa Jantus Lewinte. |